Atom Therapeutics

Hangzhou, China · Founded 2012 · In IPO Registration

Developer and researcher of new drugs and treatments designed to treat metabolic diseases and cancers. Atom Therapeutics is based in Hangzhou, China and was founded in 2012. Its last reported valuation was $425 million in Aug 2025. It has raised $70 million.

Last reported valuation
$425.1M
Oct 2026
Priced at
—
Total raised
$70.0M
Last round
—

Who backs Atom Therapeutics?

15 investors
InvestorType
Suzhou Oriza Holdings CorporationAsset manager
HSG (Hong Kong)Other
Fortune CapitalVenture capital
Shenzhen Yifeng Investment Management EnterpriseVenture capital
Heda VenturesOther
Shenzhen GTJA Investment GroupOther
Xinyi Asset ManagementOther
Youchoose CapitalOther
Beijing Xicheng Jinrui Equity Investment Fund Management—
ENN Energy Holdings—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Atom Therapeutics investors

Free account
More of Atom Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Atom Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Atom Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View